Latest 麻豆女优 Health News Stories
Unused Johnson & Johnson Covid Doses Are Piling Up as FDA Waits to See if Shelf Life Can Be Extended
As vaccine expiration dates loom, states with hundreds of thousands of doses on hand say demand is tanking and there鈥檚 no easy way to donate to other states or countries that might want them
Biden Administration Signals It鈥檚 in No Rush to Allow Canadian Drug Imports
Federal officials asked a court to dismiss a suit by drugmakers over the policy enacted by the Trump administration that would allow states to bring in cheaper prescription medications from Canada. The filing said the lawsuit was moot because it鈥檚 unclear when or if the FDA would approve any state鈥檚 importation plan.
The number of Americans 65 and older is expected to nearly double in the next 40 years. Finding a way to provide and pay for the long-term health services they need won’t be easy.
KHN鈥檚 鈥榃hat the Health?鈥: The Return of the Public Option
Lawmakers are working on fleshing out the concept of a 鈥減ublic option,鈥 a government-run or heavily regulated insurance plan that would compete with private insurance. But the details are complicated, both substantively and politically. Meanwhile, bioethicists are debating whether the U.S. should be vaccinating low-risk adolescents against covid-19 while high-risk adults in other countries are still waiting. Margot Sanger-Katz of The New York Times, Alice Miranda Ollstein of Politico and Rachana Pradhan of KHN join KHN鈥檚 Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.
KHN鈥檚 鈥榃hat the Health?鈥: Roe v. Wade on the Ropes
The newly conservative Supreme Court will hear a case that could overturn the nationwide right to abortion and cause political upheaval. Meanwhile, the Centers for Disease Control and Prevention鈥檚 abrupt announcement that vaccinated people can take off their masks in most places has caused upheaval of its own. Alice Miranda Ollstein of Politico, Sarah Karlin-Smith of the Pink Sheet and Mary Ellen McIntire of CQ Roll Call join KHN鈥檚 Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.
KHN鈥檚 鈥榃hat the Health?鈥: Drug Price Effort Hits a Snag
Democratic leaders in Congress have vowed to pass legislation to address high prescription drug prices this year, but some moderates in their own party appear to be balking. Meanwhile, younger teens are now eligible for a covid-19 vaccine and the Biden administration reinstated anti-discrimination policy for LGBTQ people in health care. Joanne Kenen of Politico, Sarah Karlin-Smith of the Pink Sheet and Rachel Cohrs of Stat join KHN鈥檚 Julie Rovner to discuss these issues and more.
Biden Boasts About Equitable Senior Vaccination Rate by Race Without Data to Back It Up
There is no public national data source that tracks vaccination rates based on a combination of race or ethnicity as well as age. Most state-level data shows that disparities exist in vaccine rates between white people and people of color.
KHN鈥檚 鈥榃hat the Health?鈥: Sharing Vaccines With the World
The Biden administration is bucking the drug industry and backing a waiver of covid-19 vaccine patent protections to help the rest of the world vaccinate its populations. Here at home, the Food and Drug Administration wants to ban menthol flavorings for cigarettes, setting off a fight with the tobacco industry. Alice Miranda Ollstein of Politico, Tami Luhby of CNN and Kimberly Leonard of Business Insider join KHN鈥檚 Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.
Democrats Disagree About How to Spend Potential Prescription Drug Windfall
After a year of uncharacteristically being on the same page when it comes to health care, Democratic lawmakers are at loggerheads about what to do next. Most agree the time is ripe to tackle high drug prices. But they divide over whether to take savings from that to move to a 鈥楳edicare for All鈥 insurance system, enhance the current Medicare program or strengthen benefits under the Affordable Care Act.
Journalists Track Biden’s First 100 Days
KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here鈥檚 a collection of their appearances.
KHN鈥檚 鈥榃hat the Health?鈥: 100 Days of Health Policy
It鈥檚 100 days into Joe Biden鈥檚 presidency and a surprisingly large number of health policies have been announced. But health is notably absent from the administration鈥檚 $1.8 trillion spending plan for American families, making it unclear how much more will get done this year. Meanwhile, the Centers for Disease Control and Prevention loosens its mask-wearing recommendations for those who have been vaccinated, but the new rules are confusing. Joanne Kenen of Politico, Mary Ellen McIntire of CQ Roll Call and Sarah Karlin-Smith of the Pink Sheet join KHN鈥檚 Julie Rovner to discuss these issues and more. Plus, Rovner interviews KHN鈥檚 Julie Appleby, who reported the latest KHN-NPR 鈥淏ill of the Month鈥 episode.
A ‘Dose of Hope’? Fact-Checking President Joe Biden’s First Speech to Congress
In his first speech before a joint session of Congress, President Joe Biden argued it was time to turn the coronavirus pandemic into a historic opportunity to expand government for the benefit of a wider range of Americans, urging investments in jobs, climate change, child care, infrastructure and more.
Evaluating President Joe Biden鈥檚 First 100 Days in Office
Presidential historians say that Joe Biden鈥檚 first 100 days in office 鈥 a somewhat arbitrary but frequently cited milestone 鈥 have included an above-average number of major accomplishments.
KHN鈥檚 鈥榃hat the Health?鈥: Picking Up the Pace of Undoing Trump Policies
The Biden administration has started to speed efforts to reverse health policies forged under Donald Trump. Most recently, the administration overturned a ban on fetal tissue research and canceled a last-minute extension of a Medicaid waiver for Texas. That latter move may delay the Senate confirmation of President Joe Biden鈥檚 nominee to head the Medicare and Medicaid programs, as Sen. John Cornyn (R-Texas) seeks to fight back. Anna Edney of Bloomberg News, Rachel Cohrs of Stat and Alice Miranda Ollstein of Politico join KHN鈥檚 Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.
KHN鈥檚 鈥榃hat the Health?鈥: Pause and Effect on Covid Vaccines
Podcast panelists discuss a range of health policy developments, from the latest in the covid vaccination effort to the HHS budget, among other things.
FDA Seeks a New Way to Review Old Drugs Without Causing Prices to Soar
A misguided federal program called the Unapproved Drugs Initiative, which put the FDA鈥檚 stamp of approval on old drugs, led to higher prices. It鈥檚 scrapped. So now what?
Biden Moves to Overturn Trump Birth Control Rules
Return to pre-Trump policy is second win of the week for abortion-rights backers.
Biden Seeks $400 Billion to Buttress Long-Term Care. A Look at What鈥檚 at Stake.
Long-term care options are expensive and often out of reach for seniors and people with disabilities. The president has proposed a massive infusion of federal funding for home and community-based health services that advocates say will go a long way toward helping individuals and families.
鈥楨xplained by KHN鈥: Health Insurance Help in Covid Relief Law
In this edition of 鈥淓xplained by KHN鈥 Emmarie Huetteman covers how the $1.9 trillion covid relief law will make health insurance coverage significantly more affordable for millions of people.
KHN鈥檚 鈥榃hat the Health?鈥: Health Care as Infrastructure
President Joe Biden鈥檚 infrastructure proposal includes items not traditionally considered 鈥渋nfrastructure,鈥 including a $400 billion expansion of home and community-based services for seniors and people with disabilities, and a $50 billion effort to replace water pipes lined with lead. Meanwhile, the politics of covid-19 are turning to how or whether Americans will need to prove they鈥檝e been vaccinated. Joanne Kenen of Politico, Tami Luhby of CNN and Sarah Karlin-Smith of the Pink Sheet join KHN鈥檚 Julie Rovner to discuss these issues and more. Plus, Rovner interviews 麻豆女优鈥檚 Mollyann Brodie about the 麻豆女优 COVID-19 Vaccine Monitor.
